OLMESARTAN MEDOXOMIL Drug Patent Profile

Which patents cover Olmesartan Medoxomil, and what generic alternatives are available?

Olmesartan Medoxomil is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma, Breckenridge, Glenmark Pharms Ltd, Inventia, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Prinston Inc, Qilu, Rising, Sandoz, Sciegen Pharms Inc, Sunshine, Teva Pharms Usa, Torrent, Umedica, Zydus Pharms, Natco Pharma Usa, and Par Pharm Inc. and is included in thirty-six NDAs.

The generic ingredient in OLMESARTAN MEDOXOMIL is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are fifty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.

Summary for OLMESARTAN MEDOXOMIL

US Patents:	0
Applicants:	25
NDAs:	36
Finished Product Suppliers / Packagers:	28
Raw Ingredient (Bulk) Api Vendors:	133
Clinical Trials:	80
Patent Applications:	4,600
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for OLMESARTAN MEDOXOMIL
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OLMESARTAN MEDOXOMIL
What excipients (inactive ingredients) are in OLMESARTAN MEDOXOMIL?	OLMESARTAN MEDOXOMIL excipients list
DailyMed Link:	OLMESARTAN MEDOXOMIL at DailyMed

See drug prices for OLMESARTAN MEDOXOMIL

Recent Clinical Trials for OLMESARTAN MEDOXOMIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
EMS	Phase 3
Seoul National University Bundang Hospital	Phase 4
Shenzhen People's Hospital	Phase 2

See all OLMESARTAN MEDOXOMIL clinical trials

Pharmacology for OLMESARTAN MEDOXOMIL

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for OLMESARTAN MEDOXOMIL

Angiotensin II Type 1 Receptor Blockers

Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for OLMESARTAN MEDOXOMIL

C09CA	Angiotensin II receptor blockers (ARBs), plain
C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

Paragraph IV (Patent) Challenges for OLMESARTAN MEDOXOMIL

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
BENICAR	Tablets	olmesartan medoxomil	5 mg, 20 mg and 40 mg	021286	1	2006-04-25

US Patents and Regulatory Information for OLMESARTAN MEDOXOMIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	209281-003	Feb 7, 2019	AB	RX	No	No
Par Pharm Inc	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	206137-002	Oct 26, 2016	AB	RX	No	No
Prinston Inc	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	206720-002	Dec 2, 2022	AB	RX	No	No
Macleods Pharms Ltd	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	204814-002	Apr 24, 2017	AB	RX	No	No
Prinston Inc	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	207804-002	Apr 24, 2017	AB	RX	No	No
Torrent	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	203580-005	Oct 26, 2016	AB	RX	No	No
Sandoz	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	090237-001	Apr 13, 2020		DISCN	No	No